Vaccines, Blood & Biologics
-
ReFacto
Proper Name: Antihemophilic Factor (Recombinant)
Tradename: ReFacto
Manufacturer: Genetics Institute, Inc, License #1163
Indication:
- Control and prevention of hemorrhagic episodes and for short-term routine and surgical prophylaxis in patients with hemophilia A
-
-
-
Related Information
FDA Online Label Repository
Search this database for drug labeling and other information. The content has not been altered or verified by the FDA and may not be the labeling on currently distributed products or identical to the labeling that is approved.
-
Contact FDA
(800) 835-4709
(301) 827-1800
Consumer Affairs Branch (CBER)
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448
-
-